Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual CysLT1/ CysLT2 receptor antagonist for asthma

Sep. 30, 2005

COL-3 blocks PKC activity and histamine release in mast cells

Sep. 30, 2005

Antiasthmatic actions of L-97-1 in preclinical tests

Sep. 28, 2005

AstraZeneca submits NDA for Symbicort

Sep. 28, 2005

Lomucin studied in phase II trial for cystic fibrosis

Sep. 28, 2005

New therapeutic agents disclosed for respiratory disorders

Sep. 26, 2005

Phase II data on rEV-131 in seasonal allergic rhinitis

Sep. 26, 2005

Beta-2 adrenergic agonist carmoterol interacts positively with budesonide and tiotropium

Sep. 26, 2005

ADAM33 gene involved in embryonic airway development and determines severity of COPD

Sep. 22, 2005

Aridol lung function test enters phase II clinical evaluation for COPD

Sep. 21, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...